Connecting clinical trial testing and advanced diagnostic capabilities to accelerate patient access to therapies

Recognizing that Labcorp was uniquely positioned to integrate drug development and diagnostic solutions, a global pharmaceutical sponsor asked Labcorp to seamlessly support their entire rare disease portfolio - from nonclinical research to clinical trial testing along with the development of companion diagnostics (CDx) to capitalize on their biomarker strategy and identify the right patients for therapy post-FDA approval.

Filed In

Labs & Centralized Testing
Rare Disease